PITUITARY APOPLEXY

This adverse event was reported 176 times

These drugs are most commonly taken by patients reporting PITUITARY APOPLEXY:

# Drug Count
0 CABERGOLINE 30
1 LEUPROLIDE ACETATE 19
2 APIXABAN 14
3 ASPIRIN 10
4 ASPIRIN 325 MG 10
5 ASPIRIN 81 MG 10
6 METFORMIN 10
7 METFORMIN ER 500 MG 10
8 METFORMIN ER 750 MG 10
9 CLOPIDOGREL 9
See all common drugs associated with PITUITARY APOPLEXY

PITUITARY APOPLEXY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CABERGOLINE 30 0.0061
1 QUAZEPAM 1 0.0033
2 BUPIVACAINE HYDROCHLORIDE WITH DEXTROSE 1 0.0022
3 TRIPTORELIN 7 0.0021
4 PASIREOTIDE 3 0.0013
5 ZAFIRLUKAST 1 0.0011
6 REGADENOSON 4 0.0008
7 OXYTOCIN 2 0.0007
8 TESTOSTERONE ENANTHATE 1 0.0006
9 CALCIUM ACETATE 3 0.0006
See all drugs enriched for association with PITUITARY APOPLEXY

PITUITARY APOPLEXY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Ergot Derivative [EPC] 30 0.0061
1 alpha-1 Adrenergic Agonist [EPC] 3 0.0007
2 Oxytocic [EPC] 2 0.0007
3 Adenosine Receptor Agonist [EPC] 4 0.0005
4 Androgen [EPC] 5 0.0002
5 Radiographic Contrast Agent [EPC] 4 0.0002
6 Somatostatin Analog [EPC] 1 0.0001
7 Factor Xa Inhibitor [EPC] 18 0.0001
8 Recombinant Human Growth Hormone [EPC] 1 0.0000
9 Opioid Agonist [EPC] 10 0.0000
See all drug classes enriched for association with PITUITARY APOPLEXY